This site is intended for healthcare professionals only
LoginRegister
Bristol Myers Squibb to discontinue trial for colorectal cancer treatmentBristol Myers Squibb to discontinue trial for colorectal cancer treatment
State-Wide Immunization Drive in Haryana Targets High-Risk AreasMelanoma vaccine could be available by 2025: Moderna CEO
Sanofi to buy Vigil Neuroscience in USD 470 million dealPfizer concludes USD 43 billion acquisition of Seagen
Strides, Incepta partner to expand women health access with WHO prequalified contraceptiveAstraZeneca India, Roche Diagnostics India collaborate to improve diagnostic testing for breast...
Sun Pharma, Philogen complete patient enrollment in Phase III trial for Soft Tissue SarcomaSun Pharma gets CDSCO panel nod to manufacture, and market Etifoxine HCL capsules for anxiety
Gujarat flag bearer of Indias pharma industry, says State govtGujarat flag bearer of India's pharma industry, says State govt
Lupin bags USFDA nod for Allopurinol TabletsLupin bags USFDA nod for Allopurinol Tablets
Seizure drug: Zydus Lifesciences gets USFDA approval for Lacosamide tabletsSeizure drug: Zydus Lifesciences gets USFDA approval for Lacosamide tablets
Granules Pharma facility gets 5 USFDA observationsGranules Pharma facility gets 5 USFDA observations
Lupin Launches Epilepsy, Migraine Drug Topiramate XR in US, Targets USD 164 Million MarketUSFDA gives tentative nod for Lupin diabetes drug Sitagliptin
COPD treatment: CDSCO nod to AstraZeneca India to market triple drug combination inhalation aerosolCOPD treatment: CDSCO nod to AstraZeneca India to market triple drug combination inhalation aerosol
European Commission authorises ViiV Healthcare Vocabria plus Rekambys for HIV treatment in adolescentsZydus Lifesciences bags USFDA nod for HIV-1 drug Darunavir
X